Blake Byers

Blake Byers is a co-founder of NewLimit, a company operating in the biotechnology research sector. NewLimit extending human healthspan. Based in San Francisco, California, United States, Blake leads the company's strategic vision and day-to-day operations.

Under Blake's leadership, NewLimit recently secured $130M in Series B funding on May 6, 2025, backed by investors including Kleiner Perkins. This funding milestone reflects strong investor confidence in both the founding team's execution capabilities and the company's market opportunity.

With fresh capital, Blake and the team are focused on scaling operations, expanding the product roadmap, and building out a world-class team. The biotechnology research market continues to see significant investment activity, positioning NewLimit to capitalize on growing demand.For vendors and partners, this represents an ideal window to engage.